Background/Aims Exclusive enteral nutrition (EEN), an established modality for pediatric Crohn’s disease (CD) is seldomly utilized in adults. The present study reports the outcome of EEN in adult CD patients at a tertiary care hospital in India.
Methods This was a retrospective analysis of CD patients who received EEN as a sole modality/adjunct to other treatment. The primary and secondary outcomes changed in Crohn’s Disease Activity Index (CDAI), and clinical response (decline in CDAI > 70), respectively, at 4 and 8 weeks. Subgroup analysis evaluated response across different phenotypes, EEN formulations and prior treatment. Linear mixed effect model was created to assess the predictors of EEN response.
Results Thirty-one CD patients received EEN over median duration of 4 weeks (range, 2–6 weeks). CDAI showed a significant improvement post EEN at 4 (baseline 290 [260–320] vs. 240 [180–280], P= 0.001) and 8 weeks (baseline 290 [260–320] vs. 186 [160–240], P= 0.001), respectively. The cumulative clinical response rates at 4 and 8 weeks were 37.3% and 80.4% respectively. The clinical response rates at 8 weeks across B1 (n = 4), B2 (n = 18) and B3 (n = 9) phenotypes were 50%, 78.8% and 100% respectively (log-rank test, P= 0.093). The response rates at 8 weeks with polymeric (n = 8) and semi-elemental diet (n = 23) were 75% and 82.6%% respectively (log-rank test, P= 0.49). Baseline CDAI (odds ratio, 1.008; 95% confidence interval, 1.002–1.017; P= 0.046) predicted response to EEN.
Conclusions EEN was effective in inducing clinical response across different phenotypes of CD. Baseline disease activity remained the most important predictor of clinical response to EEN.
Citations
Citations to this article as recorded by
Adjunct polymeric exclusive enteral nutrition helps achieve biochemical remission in active Crohn’s disease in adults irrespective of disease location and concomitant corticosteroid use Hellen Kuo, Katrina Tognolini, Rumbidzai Mutsekwa, Dheeraj Shukla, Laura Willmann, Hadi Moattar, Alexander Dorrington, Naveed Ishaq, Maneesha Bhullar, John Edwards, Waled Mohsen, Pradeep Kakkadasam Ramaswamy Frontline Gastroenterology.2025; 16(1): 3. CrossRef
Inflammatory bowel disease in south Asia: a scoping review Shabari Shenoy, Anuraag Jena, Carrie Levinson, Vishal Sharma, Parakkal Deepak, Tina Aswani-Omprakash, Shaji Sebastian, Jean-Frederic Colombel, Manasi Agrawal The Lancet Gastroenterology & Hepatology.2025; 10(3): 259. CrossRef
Enteral Nutrition in Crohn’s Disease: A Comprehensive Review of Its Role in Induction and Maintenance of Remission and Perioperative Management in Adult Patients André Bargas, Carolina Palmela, Luisa Glória Nutrients.2025; 17(9): 1481. CrossRef
Pancreatic Enzyme Replacement Therapy Improves Exclusive Enteral Nutrition Related Diarrhea in Crohn's Disease: A Prospective Randomized Trial Jian Kang, Jing Wang, Juan Su, Wei Wang, Yueyue Lu, Zhishun Tang, Liping Zou, Anning Yin, Jiao Li, Haixia Ren, Qian Zhou, Huipeng Wan, Ping An United European Gastroenterology Journal.2025;[Epub] CrossRef
Progress and Clinical Applications of Crohn’s Disease Exclusion Diet in Crohn’s Disease Duo Xu, Ziheng Peng, Yong Li, Qian Hou, Yu Peng, Xiaowei Liu Gut and Liver.2024; 18(3): 404. CrossRef
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignass, Robert Ehehalt, Christoph-Thomas Germer, P. C. Grunert, Ulf Helwig, Karoline Horisberger, Klaus Herrlinger, Peter Kienle, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Zeitschrift für Gastroenterologie.2024; 62(08): 1229. CrossRef
Refractory Crohn’s Disease: Perspectives, Unmet Needs and Innovations Luisa Bertin, Martina Crepaldi, Miriana Zanconato, Greta Lorenzon, Daria Maniero, Caterina De Barba, Erica Bonazzi, Sonia Facchin, Marco Scarpa, Cesare Ruffolo, Imerio Angriman, Andrea Buda, Fabiana Zingone, Edoardo Vincenzo Savarino, Brigida Barberio Clinical and Experimental Gastroenterology.2024; Volume 17: 261. CrossRef
Use of oral diet and nutrition support in management of stricturing and fistulizing Crohn's disease Kush Fansiwala, Neha D. Shah, Kelly A. McNulty, Mary R. Kwaan, Berkeley N. Limketkai Nutrition in Clinical Practice.2023; 38(6): 1282. CrossRef
Exclusive Enteral Nutrition Orchestrates Immunological Balances as Early as Week 4 in Adult Patients of Crohn’s Disease: A Pilot, Open-Lable Study Na Diao, Xinyu Liu, Minzhi Lin, Qingfan Yang, Bingyang Li, Jian Tang, Ni Ding, Xiang Gao, Kang Chao Nutrients.2023; 15(24): 5091. CrossRef
Exclusive enteral nutrition with oral polymeric diet helps in inducing clinical and biochemical remission in adults with active Crohn's disease Pradeep Kakkadasam Ramaswamy Journal of Parenteral and Enteral Nutrition.2022; 46(2): 423. CrossRef
Is the frequency of dietitian support associated with greater clinical improvements in adults with Crohn's disease undertaking exclusive enteral nutrition? Liz Purcell, Rumbidzai Mutsekwa, Rebecca Angus, Dheeraj Shukla, Michelle Palmer Journal of Human Nutrition and Dietetics.2022; 35(3): 435. CrossRef
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004 Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignaß, Robert Ehehalt, Christoph Germer, Philip C. Grunert, Ulf Helwig, Klaus Herrlinger, Peter Kienle, Martin E. Kreis, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Johann Oc Zeitschrift für Gastroenterologie.2022; 60(03): 332. CrossRef
Diet and nutrition in the management of inflammatory bowel disease Pabitra Sahu, Saurabh Kedia, Vineet Ahuja, Rakesh K. Tandon Indian Journal of Gastroenterology.2021; 40(3): 253. CrossRef
Review of exclusive enteral therapy in adult Crohn’s disease Nikola Mitrev, Hin Huang, Barbara Hannah, Viraj Chandana Kariyawasam BMJ Open Gastroenterology.2021; 8(1): e000745. CrossRef
Current Use of EEN in Pre-Operative Optimisation in Crohn’s Disease Sharafaath Shariff, Gordon Moran, Caris Grimes, Rachel Margaret Cooney Nutrients.2021; 13(12): 4389. CrossRef
Exclusive Enteral Nutrition in Adult Crohn’s Disease: an Overview of Clinical Practice and Perceived Barriers Roberto de Sire, Olga Maria Nardone, Anna Testa, Giulio Calabrese, Anna Caiazzo, Fabiana Castiglione Clinical and Experimental Gastroenterology.2021; Volume 14: 493. CrossRef
Making Decisions about Dietary Therapy in Inflammatory Bowel Disease Sydney Solomon, Eunie Park, Joseph A. Picoraro Gastrointestinal Disorders.2020; 2(4): 353. CrossRef
EEN Yesterday and Today … CDED Today and Tomorrow Marta Herrador-López, Rafael Martín-Masot, Víctor Manuel Navas-López Nutrients.2020; 12(12): 3793. CrossRef
Background/Aims Gluten-free diet has an excess of fats and simple sugars and puts patients with celiac disease at risk of metabolic complications including metabolic syndrome and fatty liver. We assessed prevalence of metabolic syndrome and fatty liver in two cohorts of celiac disease.
Methods Study was done in 2 groups. In group 1, 54 treatment naïve patients with celiac disease were recruited. Of them, 44 returned after 1-year of gluten-free diet and were reassessed. In group 2, 130 celiac disease patients on gluten-free diet for ≥1 year were recruited. All patients were assessed for anthropometric and metabolic parameters and fatty liver. Metabolic syndrome was defined as per consensus definition for Asian Indians. Fatty liver was defined as controlled attenuation parameter value >263 decibels by FibroScan.
Results In group 1, of 44 treatment naïve patients with celiac disease, metabolic syndrome was present in 5 patients (11.4%) at baseline and 9 (18.2%) after 1 year of gluten-free diet. Patients having fatty liver increased from 6 patients (14.3%) at baseline to 13 (29.5%) after 1year of gluten-free diet (P=0.002). In group 2, of 130 patients with celiac disease on gluten-free diet for a median duration of 4 years, 30 out of 114 (26.3%) and 30 out of 130 patients (23%) had metabolic syndrome and fatty liver, respectively.
Conclusions Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver, which increases further with gluten-free diet. These patients should be assessed for nutritional and metabolic features and counseled about balanced diet and physical activity regularly.
Citations
Citations to this article as recorded by
Dietary assessments in individuals living with coeliac disease: key considerations Anne R. Lee, Melinda Dennis, Jessica Lebovits, Lori Welstead, Ritu Verma, Amelie Therrien, Benjamin Lebwohl Journal of Human Nutrition and Dietetics.2025;[Epub] CrossRef
Exploring the link between celiac disease and obesity: a potential role of gut microbiome Sunaina Addanki, Anastasia Mashukova, Arkene Levy Intestinal Research.2025; 23(2): 193. CrossRef
Efficacy of Antiobesity Medications in Patients With Celiac Disease on a Gluten-free Diet Diego Anazco, Sima Fansa, Wissam Ghusn, Khushboo Gala, Bryan Nicolalde, Elif Tama, Gerardo Calderon, Adam C. Bledsoe, Maria D. Hurtado, Joseph A. Murray, Andres Acosta Journal of Clinical Gastroenterology.2024; 58(7): 650. CrossRef
Guidelines for best practices in monitoring established coeliac disease in adult patients Luca Elli, Daniel Leffler, Christophe Cellier, Benjamin Lebwohl, Carolina Ciacci, Michael Schumann, Knut E. A. Lundin, Stefania Chetcuti Zammit, Reena Sidhu, Leda Roncoroni, Julio C. Bai, Anne R. Lee, Melinda Dennis, Marie E. Robert, Kamran Rostami, Sheri Nature Reviews Gastroenterology & Hepatology.2024; 21(3): 198. CrossRef
Probiotic Interventions in Coeliac Disease: A Systematic Review with a Focus on Cardiovascular Risk Lorretta Olu Fagbemi, Carlo Soldaini, Adele Costabile, Sofia Kolida, Carolina Ciacci, Yvonne Jeanes Gastrointestinal Disorders.2024; 6(1): 114. CrossRef
Metabolomics and lipidomics signature in celiac disease: a narrative review Mohammad Rostami-Nejad, Nastaran Asri, Sajjad Bakhtiari, Ensieh Khalkhal, Sepehr Maleki, Mostafa Rezaei-Tavirani, Somayeh Jahani-Sherafat, Kamran Rostami Clinical and Experimental Medicine.2024;[Epub] CrossRef
Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study Shuai Yuan, Dan Leffler, Benjamin Lebwohl, Peter H. R. Green, Jiangwei Sun, Sofia Carlsson, Susanna C. Larsson, Jonas F. Ludvigsson Diabetologia.2024; 67(8): 1630. CrossRef
Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease Hye Kyung Hyun, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon European Journal of Gastroenterology & Hepatology.2024; 36(4): 445. CrossRef
The Impact of a Gluten-Free Diet on Pregnant Women with Celiac Disease: Do We Need a Guideline to Manage Their Health? Yeliz Serin, Camilla Manini, Pasqualino Amato, Anil K. Verma Gastrointestinal Disorders.2024; 6(3): 675. CrossRef
The Effects of Gluten-free Diet on Body Mass Indexes in Adults with Celiac Disease Noam Peleg, Yaron Niv, Ram Dickman, Doron Boltin, Alex Krauthammer, Michal Herman-Edelstein, Nidal Issa, Jacob E. Ollech, Tom Konikoff, Rachel Gingold-Belfer Journal of Clinical Gastroenterology.2024; 58(10): 989. CrossRef
Nutrition Assessment and Management in Celiac Disease M. Ines Pinto-Sanchez, Jedid-Jah Blom, Peter R. Gibson, David Armstrong Gastroenterology.2024;[Epub] CrossRef
Celiac disease - a pluripathological model in pediatric practice Vasile Valeriu Lupu, Maria Oana Sasaran, Elena Jechel, Iuliana Magdalena Starcea, Ileana Ioniuc, Adriana Mocanu, Solange Tamara Rosu, Valentin Munteanu, Alin Horatiu Nedelcu, Ciprian Danielescu, Delia Lidia Salaru, Anton Knieling, Ancuta Lupu Frontiers in Immunology.2024;[Epub] CrossRef
Patients with Celiac Disease Have High Prevalence of Fatty Liver and Metabolic Syndrome Nishant Aggarwal, Ashish Agarwal, Hasan Alarouri, Vignesh Dwarakanathan, Sana Dang, Vineet Ahuja, Govind K. Makharia Digestive Diseases and Sciences.2024; 69(8): 3029. CrossRef
Past, Present, and Future of Noninvasive Tests to Assess Gluten Exposure, Celiac Disease Activity, and End-Organ Damage Jocelyn A. Silvester, Luca Elli, Chaitan Khosla, Jason A. Tye-Din Gastroenterology.2024; 167(1): 159. CrossRef
The Economic Iceberg of Celiac Disease: More Than the Cost of Gluten-Free Food Soran R. Bozorg, Anne R. Lee, Karl Mårild, Joseph A. Murray Gastroenterology.2024;[Epub] CrossRef
Gluten-free foods are expensive and nutritionally imbalanced than their gluten-containing counterparts Wajiha Mehtab, Samagra Agarwal, Harsh Agarwal, Anam Ahmed, Ashish Agarwal, Shubham Prasad, Ashish Chauhan, Anjali Bhola, Namrata Singh, Vineet Ahuja, Anita Malhotra, Govind K Makharia Indian Journal of Gastroenterology.2024; 43(3): 668. CrossRef
Letter: Breaking new ground—Understanding the role of ATI‐free diet in managing MASLD Matteo Spertino, Rossi Roberta Elisa, Nicola Pugliese Alimentary Pharmacology & Therapeutics.2024; 60(2): 302. CrossRef
Gluten-Free Diet—What’s Good for Celiac Disease Can Be Bad for Metabolism Kathleen Viveiros, Sonal Kumar Digestive Diseases and Sciences.2024; 69(8): 2721. CrossRef
Influence of a structured, 1-year-long dietary intervention regarding body composition and cardiovascular risk (ARCTIC) in coeliac disease: a protocol of a multicentre randomised controlled trial Zsófia Vereczkei, Zsolt Szakács, Míra Zsófia Peresztegi, Klára Lemes, Krisztina Hagymási, Sarolta Dakó, Eszter Dakó, Szilvia Lada, Nándor Faluhelyi, Gábor Szekeres, Gyula Pásztor, Nelli Farkas, Gabriella Pár, Emese Mezősi, Judit Bajor BMJ Open.2024; 14(10): e084365. CrossRef
The prevalence of obesity and underweight in celiac patients at the time of diagnosis: a systematic review and meta-analysis Farzad Maleki, Marjan Hosseinpour, Ali Delpisheh, Mansour Bahardoust, Fatemeh Hajizadeh-Sharafabad, Mohammad Reza Pashaei BMC Gastroenterology.2024;[Epub] CrossRef
Reuse of Almond Skin to Formulate a New Gluten- and Lactose-Free Bakery Product Lucia Francesca Vuono, Vincenzo Sicari, Antonio Mincione, Rosa Tundis, Roberta Pino, Natale Badalamenti, Maurizio Bruno, Francesco Sottile, Sonia Piacente, Luca Settanni, Monica Rosa Loizzo Foods.2024; 13(23): 3796. CrossRef
Celiac Disease and Liver Damage: The Gut–Liver Axis Strikes Back (Again)? A Retrospective Analysis in the Light of a Literature Review Aurelio Seidita, Federica Latteri, Mirco Pistone, Alessandra Giuliano, Luca Bertoncello, Giorgia Cavallo, Marta Chiavetta, Francesco Faraci, Alessia Nigro, Alessandro Termini, Laura Verona, Agnese Ammannato, Salvatore Accomando, Francesca Cavataio, Maria Nutrients.2024; 17(1): 85. CrossRef
Gluten: do only celiac patients benefit from its removal from the diet? Laryssa Rosa de Sousa Franckilin, Anna Clara Paiva Menezes Dos Santos, Flávio Eduardo Dias Araújo Freitas, Isabela Garbazza Vieira, Carlos Eduardo de Freitas Jorge, Daniela Godoy Neri, Maria Vitória Cota de Abreu, Janaina Koenen Fonseca, Renato Guimarães Food Reviews International.2023; 39(7): 4388. CrossRef
Risk of obesity during a gluten-free diet in pediatric and adult patients with celiac disease: a systematic review with meta-analysis Michele Barone, Andrea Iannone, Fernanda Cristofori, Vanessa Nadia Dargenio, Flavia Indrio, Elvira Verduci, Alfredo Di Leo, Ruggiero Francavilla Nutrition Reviews.2023; 81(3): 252. CrossRef
Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine Mihaela Simona Popoviciu, Nirja Kaka, Yashendra Sethi, Neil Patel, Hitesh Chopra, Simona Cavalu Journal of Personalized Medicine.2023; 13(3): 422. CrossRef
Celiac Disease and Cardiovascular Risk: A Retrospective Case-Control Study Maria Pina Dore, Sandro Mereu, Pier Sergio Saba, Michele Portoghese, Giovanni Mario Pes Journal of Clinical Medicine.2023; 12(6): 2087. CrossRef
Nutritional status, nutrient imbalances, food-related behaviors and dietary supplements use among patients with celiac disease on a gluten free diet in Lebanon: a national cross-sectional study Maha Hoteit, Zeinab Chamas, Shaza Assaf, Malek Michael Bouhairie, Abbas Bahr, Romy Daccache, Rami Matar, Mahmoud Hallal, Samer Hotayt, Bilal Hotayt F1000Research.2023; 11: 725. CrossRef
Fatty liver and celiac disease: Why worry? Janaina Luz Narciso-Schiavon, Leonardo Lucca Schiavon World Journal of Hepatology.2023; 15(5): 666. CrossRef
Prevalence of autoimmune, cholestatic and nonalcoholic fatty liver disease in celiac disease Asif Ali Hitawala, Ashraf Almomani, Somtochukwu Onwuzo, Antoine Boustany, Prabhat Kumar, Imad Asaad European Journal of Gastroenterology & Hepatology.2023; 35(9): 1030. CrossRef
Body Mass Index during Gluten-Free Diet in Patients with Celiac Disease Zsófia Vereczkei, Tímea Dergez, Zsuzsanna Fodor, Zsolt Szakács, Judit Bajor Nutrients.2023; 15(16): 3517. CrossRef
Obesity and Colorectal Cancer Jundeok Lee, Su Young Kim The Korean Journal of Gastroenterology.2023; 82(2): 63. CrossRef
Incidentally Discovered Cryptogenic Cirrhosis in a Patient with Untreated Celiac Disease Kelli Kosako Yost, Yasmin Alishahi Galician Medical Journal.2023; 30(3): E202336. CrossRef
The association of interleukin-10 single nucleotide polymorphisms (rs1800871) and serum levels in Iraqi patients with celiac disease: A case-control study Ali Hafedh Abbas, Sahar Taha Hatif, Faiq Isho Gorial, Sara Bayan Ali Clinical Epidemiology and Global Health.2023; 24: 101437. CrossRef
Unveiling the Link: A Comprehensive Narrative Review of the Relationship Between Type 1 Diabetes Mellitus and Celiac Disease Sanvi Arora, Ayush Tayade, Tanya Bhardwaj, Swanand S Pathak Cureus.2023;[Epub] CrossRef
Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis Shalimar, Anshuman Elhence, Bhavik Bansal, Hardik Gupta, Abhinav Anand, Thakur P. Singh, Amit Goel Journal of Clinical and Experimental Hepatology.2022; 12(3): 818. CrossRef
Nutritional status, nutrient imbalances, food-related behaviors and dietary supplements use among patients with celiac disease in Lebanon: a national cross-sectional study Maha Hoteit, Zeinab Chamas, Shaza Assaf, Malek Michael Bouhairie, Abbas Bahr, Romy Daccache, Rami Matar, Marwa Hallal, Michael Maitar, Mahmoud Hallal, Samer Hotayt, Bilal Hotayt F1000Research.2022; 11: 725. CrossRef
Eating Competence and Aspects Related to a Gluten-Free Diet in Brazilian Adults with Gluten-Related Disorders Pâmela Mayara de Oliveira, Renata Puppin Zandonadi, Amanda Moreira Veloso Cutrim, Eduardo Yoshio Nakano, Fabiana Lopes Nalon de Queiroz, Raquel B. A. Botelho, Ariana Saraiva, António Raposo Nutrients.2022; 14(14): 2815. CrossRef
Nutritional status, nutrient imbalances, food-related behaviors and dietary supplements use among patients with celiac disease on a gluten free diet in Lebanon: a national cross-sectional study Maha Hoteit, Zeinab Chamas, Shaza Assaf, Malek Michael Bouhairie, Abbas Bahr, Romy Daccache, Rami Matar, Marwa Hallal, Mahmoud Hallal, Samer Hotayt, Bilal Hotayt F1000Research.2022; 11: 725. CrossRef
Multidimensional Disadvantages of a Gluten-Free Diet in Celiac Disease: A Narrative Review Martyna Marciniak, Aleksandra Szymczak-Tomczak, Dagmara Mahadea, Piotr Eder, Agnieszka Dobrowolska, Iwona Krela-Kaźmierczak Nutrients.2021; 13(2): 643. CrossRef
The Healthy Gluten-Free Diet: Practical Tips to Prevent Metabolic Disorders and Nutritional Deficiencies in Celiac Patients Emanuele Rinninella, Marco Cintoni, Pauline Raoul, Silvia Triarico, Tommaso Dionisi, Giovanni Battista Gasbarrini, Antonio Gasbarrini, Maria Cristina Mele Gastroenterology Insights.2021; 12(2): 166. CrossRef
Nutritional Properties of Rice Varieties Commonly Consumed in Italy and Applicability in Gluten Free Diet Giorgia Vici, Diego Romano Perinelli, Dalia Camilletti, Flora Carotenuto, Luca Belli, Valeria Polzonetti Foods.2021; 10(6): 1375. CrossRef
Physical development in children with celiac disease in St. Petersburg N. S. Shapovalova, V. P. Novikova, K. A. Klikunova Experimental and Clinical Gastroenterology.2021; (4): 116. CrossRef
Celiac disease and obesity: the possibility of comboridity of pathology in children V. P. Novikova, V. L. Gritsinskaya, A. I. Khavkin Experimental and Clinical Gastroenterology.2021; (4): 124. CrossRef